|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02909257 |
|
Date of registration:
|
19/09/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Motor-Sparing Femoral Nerve Block Dose
|
|
Scientific title:
|
Minimum Effective Concentration of Bupivacaine for Motor-Sparing Femoral Nerve Block |
|
Date of first enrolment:
|
September 2016 |
|
Target sample size:
|
31 |
|
Recruitment status: |
Terminated |
|
URL:
|
https://clinicaltrials.gov/show/NCT02909257 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Double (Participant, Investigator).
|
|
Phase:
|
Phase 4
|
|
|
Countries of recruitment
|
|
Chile
| | | | | | | |
|
Contacts
|
|
Name:
|
DE QH TRAN, MD, FRCPC |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
McGill University Health Centre/Research Institute of the McGill University Health Centre |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Age between 18 and 75 years
- American Society of Anesthesiologists classification 1-3
- Body mass index between 20 and 35
Exclusion Criteria:
- Adults who are unable to give their own consent
- Pre-existing neuropathy (assessed by history and physical examination)
- Coagulopathy (assessed by history and physical examination and, if deemed clinically
necessary, by blood work up i.e. platelets= 100, International Normalized Ratio= 1.4
or partial prothrombin time = 50)
- Renal failure (assessed by history and physical examination and, if deemed clinically
necessary, by blood work up i.e. creatinine = 100)
- Hepatic failure (assessed by history and physical examination and, if deemed
clinically necessary, by blood work up i.e. transaminases = 100)
- Allergy to LA
- Pregnancy
- Prior surgery in the inguinal region
- Chronic pain syndromes requiring opioid intake at home
Age minimum:
18 Years
Age maximum:
75 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Osteoarthritis, Knee
|
|
Knee Injuries
|
|
Intervention(s)
|
|
Drug: Same Bupivacaine Concentration
|
|
Drug: Lower Bupivacaine Concentration
|
|
Primary Outcome(s)
|
|
Minimum Bupivacaine Analgesic concentration preserving quadriceps strength analgesia
[Time Frame: 5 months]
|
|
Secondary ID(s)
|
|
OAIC 823/16
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|